TBD Health, a hybrid sexual healthcare provider known for its innovative clinical care, is expanding into the B2B healthcare market. This strategic move allows digital health companies such as FOLX Health and Wisp to leverage TBD Health’s comprehensive STD/STI at-home test kits, diagnostic laboratory services, and clinical care hubs. The collaboration aims to provide equitable, stigma-free, and reliable healthcare, according to Stephanie…
3Daughters, a clinical development company dedicated to advancing healthcare for women, has successfully closed over $2 million in the initial phase of its seed funding round. The round, led by Thairm Bio and supported by the Argosy Foundation, Wexford Science and Technology, UMass Amherst, and other undisclosed investors, marks a significant step in the company’s mission to develop a new intrauterine device…
Pandia Health, a company known for its birth control treatment and delivery services, is extending its healthcare offerings to include hormonal treatment for menopause. This expansion adds a crucial service to Pandia Health’s portfolio, addressing the needs of mid-life women alongside its existing services for birth control and acne treatment. The company announced today its new Chief Executive Officer, Alice Eweida, who previously…
Daré Bioscience, a women’s health company, has announced the receipt of a $750K grant from the Bill & Melinda Gates Foundation. This funding is earmarked for the development of bacteria-based live biotherapeutic products, aiming to enhance the health of women and newborns globally. This recent grant follows a previous award of approximately $585K from the foundation, granted to Daré in November 2022…
NEXT Life Sciences, the creator of the male contraceptive product Plan A, recently announced a successful $2.5 million funding round to advance the launch of its innovative solution into the market. The Family, a high-impact startup accelerator led the round with participation from Transform VC and a combination of angel investors and early-stage venture funds including entrepreneur Brock Pierce, Transform VC, StartupHealth, Pay…
Wow wow wow. We really started the year with a bit of a bang 💥 in women’s health last week: In a somewhat historic advancement for women’s health, Qvin’s received FDA approval of the Q-Pad, an innovative menstrual blood-based health monitoring pad. Qvin’s FDA approval last week was more then just a news story, it’s really a narrative shift, positioning menstrual blood at the very center…
Initially the Oura Ring promised better sleep, but its collaboration with Natural Cycles delivered something I hadn’t envisioned: a smart, straightforward way to manage my reproductive health. Starting in August 2022, I began using an Oura Ring alongside Natural Cycles initially for contraception. This partnership has transformed my approach to fertility and contraception, evolving from a background concern into an integrated part…
Marius Pharmaceuticals, a company dedicated to developing therapies for testosterone deficiency, has launched a pilot study focusing on the effects of its oral testosterone therapy, KYZATREX (testosterone undecanoate), on male fertility, specifically spermatogenesis. KYZATREX, approved for testosterone replacement therapy in adult males with testosterone deficiency, will be the subject of this pioneering study. The study aims to explore how this oral testosterone…
